scispace - formally typeset
R

Rajesh Kumar

Researcher at Himachal Pradesh University

Publications -  6966
Citations -  180095

Rajesh Kumar is an academic researcher from Himachal Pradesh University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 149, co-authored 4439 publications receiving 140830 citations. Previous affiliations of Rajesh Kumar include Guru Nanak Dev University & Intuitive Surgical.

Papers
More filters
Journal ArticleDOI

A mutation in Arabidopsis cytochrome b5 reductase identified by high-throughput screening differentially affects hydroxylation and desaturation.

TL;DR: Interestingly, while the cbr1-1 mutation reduced the accumulation of hydroxy fatty acids in seeds by 85%, the effects on 18:1 and 18:2 desaturation reactions were much less, suggesting that there is competition in developing seeds among the several reactions that utilize reduced cytochrome b5.
Posted ContentDOI

Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)

Anup Agarwal, +261 more
- 08 Sep 2020 - 
TL;DR: This trial has high generalizability and approximates real-life setting of CP therapy in settings with limited laboratory capacity and a priori measurement of neutralizing antibody titres in donors and participants may further clarify the role of CP in management of COVID-19.
Journal ArticleDOI

Economic analysis of delivering primary health care services through community health workers in 3 North Indian states.

TL;DR: Government of India’s policy of hiring 2nd ANM at sub-centre level is very cost effective from Indian health system perspective and would be useful in undertaking full economic evaluations or equity analysis of CHW programs.
Journal ArticleDOI

Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case–control study

TL;DR: The genotype-combination analyses indicated that the best model stratifies cases and controls based on the 66A>G and the 524C>T polymorphisms in the MTRR gene, which may, in part, account for population-based differences in risk.